210 related articles for article (PubMed ID: 10701528)
21. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO
Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of paracrine immunotherapy in experimental brain tumors.
Lesniak MS; Sampath P; DiMeco F; Viglione MP; Tyler BM; Pardoll DM; Brem H
Neurosurg Focus; 2000 Dec; 9(6):e4. PubMed ID: 16817687
[TBL] [Abstract][Full Text] [Related]
23. Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors.
Manome Y; Wen PY; Hershowitz A; Tanaka T; Rollins BJ; Kufe DW; Fine HA
Cancer Immunol Immunother; 1995 Oct; 41(4):227-35. PubMed ID: 7489565
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of particulate systems supporting tumor cell fractions in a preventive vaccination against intracranial rat glioma.
Sapin A; Clavreul A; Garcion E; Benoit JP; Menei P
J Neurosurg; 2006 Nov; 105(5):745-52. PubMed ID: 17121138
[TBL] [Abstract][Full Text] [Related]
25. Systemic BCNU enhances the efficacy of local delivery of a topoisomerase I inhibitor against malignant glioma.
Storm PB; Renard VM; Moriarity JL; Tyler B; Wilentz RE; Brem H; Weingart JD
Cancer Chemother Pharmacol; 2004 Oct; 54(4):361-7. PubMed ID: 15197484
[TBL] [Abstract][Full Text] [Related]
26. Dexamethasone inhibits the anti-tumor effect of interleukin 4 on rat experimental gliomas.
Benedetti S; Pirola B; Poliani PL; Cajola L; Pollo B; Bagnati R; Magrassi L; Tunici P; Finocchiaro G
Gene Ther; 2003 Jan; 10(2):188-92. PubMed ID: 12571648
[TBL] [Abstract][Full Text] [Related]
27. Intracerebral administration of heat-inactivated Staphylococcus epidermidis enhances oncolysis and prolongs survival in a 9L orthotopic gliosarcoma model.
Löhr M; Molcanyi M; Poggenborg J; Spuentrup E; Runge M; Röhn G; Härtig W; Hescheler J; Hampl JA
Cell Physiol Biochem; 2013; 31(4-5):614-24. PubMed ID: 23652608
[TBL] [Abstract][Full Text] [Related]
28. [Experimental study of dendritic cells transfected with cancer stem like cells RNA against 9L brain tumors].
Xiao ZY; Chen XJ; Yang Y; Xu RX
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):661-6. PubMed ID: 26284406
[TBL] [Abstract][Full Text] [Related]
29. Granulocyte macrophage-colony stimulating factor gene transfer to induce a protective anti-tumoral immune response against the 9L rat gliosarcoma model.
Lefranc F; Cool V; Velu T; Brotchi J; De Witte O
Int J Oncol; 2002 May; 20(5):1077-85. PubMed ID: 11956607
[TBL] [Abstract][Full Text] [Related]
30. Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: implications for the use of dendritic cells for therapy of gliomas.
Yang T; Witham TF; Villa L; Erff M; Attanucci J; Watkins S; Kondziolka D; Okada H; Pollack IF; Chambers WH
Cancer Res; 2002 May; 62(9):2583-91. PubMed ID: 11980653
[TBL] [Abstract][Full Text] [Related]
31. Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens.
Liau LM; Black KL; Prins RM; Sykes SN; DiPatre PL; Cloughesy TF; Becker DP; Bronstein JM
J Neurosurg; 1999 Jun; 90(6):1115-24. PubMed ID: 10350260
[TBL] [Abstract][Full Text] [Related]
32. Experimental gliosarcoma induces chemokine receptor expression in rat brain.
Galasso JM; Stegman LD; Blaivas M; Harrison JK; Ross BD; Silverstein FS
Exp Neurol; 2000 Jan; 161(1):85-95. PubMed ID: 10683275
[TBL] [Abstract][Full Text] [Related]
33. Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy.
Fakhrai H; Dorigo O; Shawler DL; Lin H; Mercola D; Black KL; Royston I; Sobol RE
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2909-14. PubMed ID: 8610141
[TBL] [Abstract][Full Text] [Related]
34. [Therapeutic efficacy of intracarotid infusion of 20% mannitol with ACNU in Fischer rats with intracerebrally implanted 9L gliosarcoma].
Miyagami M; Tazoe M; Kasahara E; Tsubokawa T
Gan To Kagaku Ryoho; 1989 May; 16(5):2059-65. PubMed ID: 2499268
[TBL] [Abstract][Full Text] [Related]
35. Time course analysis and modulating effects of established brain tumor on active-specific immunotherapy.
Liu Y; Ng K; Lillehei KO
Neurosurg Focus; 2000 Dec; 9(6):e3. PubMed ID: 16817686
[TBL] [Abstract][Full Text] [Related]
36. Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors.
Sampath P; Hanes J; DiMeco F; Tyler BM; Brat D; Pardoll DM; Brem H
Cancer Res; 1999 May; 59(9):2107-14. PubMed ID: 10232596
[TBL] [Abstract][Full Text] [Related]
37. NKR-P1+ cells localize selectively in Rat 9L gliosarcomas but have reduced cytolytic function.
Chambers WH; Bozik ME; Brissette-Storkus SC; Basse P; Redgate E; Watkins S; Boggs SS
Cancer Res; 1996 Aug; 56(15):3516-25. PubMed ID: 8758920
[TBL] [Abstract][Full Text] [Related]
38. The role of minocycline in the treatment of intracranial 9L glioma.
Weingart JD; Sipos EP; Brem H
J Neurosurg; 1995 Apr; 82(4):635-40. PubMed ID: 7897527
[TBL] [Abstract][Full Text] [Related]
39. Effects of IFN-gamma and interleukin-1beta on major histocompatibility complex antigen and intercellular adhesion molecule-1 expression by 9L gliosarcoma: relevance to its cytolysis by alloreactive cytotoxic T lymphocytes.
Schiltz PM; Gomez GG; Read SB; Kulprathipanja NV; Kruse CA
J Interferon Cytokine Res; 2002 Dec; 22(12):1209-16. PubMed ID: 12581494
[TBL] [Abstract][Full Text] [Related]
40. Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take.
Kruse CA; Lillehei KO; Mitchell DH; Kleinschmidt-DeMasters B; Bellgrau D
Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9577-81. PubMed ID: 2263613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
